Cleared Traditional

K122122 - REGEN SPRAY APPLICATOR,

K122122 is an FDA 510(k) clearance for REGEN SPRAY APPLICATOR, manufactured by Regen Lab SA. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 115-day FDA review.

K122122 · Regen Lab SA · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
115d
Days
Class 2
Risk

K122122 is an FDA 510(k) clearance for the REGEN SPRAY APPLICATOR,. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Regen Lab SA (Montreal, CA). The FDA issued a Cleared decision on November 9, 2012 after a review of 115 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Regen Lab SA devices

FDA 510(k) Submission Details - K122122

510(k) Number K122122 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 2012
Decision Date November 09, 2012
Days to Decision 115 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 129d · This submission: 115d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 353
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K122122.
NAMIC RCS SYRINGE
K140194 · Navilyst Medical, Inc. · Apr 2014
MONOJECT 60ML SYRINGE (LUER LOCK TIP, LUER SLIP TIP, CATHETER TIP)
K131641 · Nipro Medical Corporation · Aug 2013
MONOJECT 12ML SYRINGE
K130049 · Nipro Medical Corporation · Feb 2013
BD EMERALD SAF-T SINGLE USE, HYPODERMIC
K121283 · Becton, Dickinson and Company · May 2012
ARTHREX MIXING AND DELIVERY SYSTEM
K121124 · Arthrex, Inc. · May 2012
MERIT MEDICAL 20 ML SYRINGE
K111091 · Merit Medical Systems, Inc. · Jun 2011